Literature DB >> 21933791

Achieving tight control in rheumatoid arthritis.

Laura T C van Hulst, Marlies E J L Hulscher, Piet L C M van Riel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21933791     DOI： 10.1093/rheumatology/ker325

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  10 in total

1.  Subjective numeracy and preference to stay with the status quo.

Authors:  Liana Fraenkel; Meaghan Cunningham; Ellen Peters
Journal:  Med Decis Making       Date:  2014-04-23       Impact factor: 2.583

2.  Understanding how patients (vs physicians) approach the decision to escalate treatment: a proposed conceptual model.

Authors:  Liana Fraenkel; Elizabeth K Seng; Meaghan Cunningham; Kristin Mattocks
Journal:  Rheumatology (Oxford)       Date:  2014-08-28       Impact factor: 7.580

3.  High disease activity may not be sufficient to escalate care.

Authors:  Liana Fraenkel; Meaghan Cunningham
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-02       Impact factor: 4.794

4.  The practitioner proposes a treatment change and the patient declines: what to do next?

Authors:  Paul R Falzer; Howard L Leventhal; Ellen Peters; Terri R Fried; Robert Kerns; Marion Michalski; Liana Fraenkel
Journal:  Pain Pract       Date:  2012-07-02       Impact factor: 3.183

5.  Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial.

Authors:  Noortje van Herwaarden; Aatke van der Maas; Michiel J M Minten; Frank H J van den Hoogen; Wietske Kievit; Ronald F van Vollenhoven; Johannes W J Bijlsma; Bart J F van den Bemt; Alfons A den Broeder
Journal:  BMJ       Date:  2015-04-09

6.  Cluster-Randomized Trial of a Behavioral Intervention to Incorporate a Treat-to-Target Approach to Care of US Patients With Rheumatoid Arthritis.

Authors:  Leslie R Harrold; George W Reed; Ani John; Christine J Barr; Kevin Soe; Robert Magner; Katherine C Saunders; Eric M Ruderman; Tmirah Haselkorn; Jeffrey D Greenberg; Allan Gibofsky; J Timothy Harrington; Joel M Kremer
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-02-06       Impact factor: 4.794

7.  The multi-biomarker disease activity test for assessing response to treatment strategies using methotrexate with or without prednisone in the CAMERA-II trial.

Authors:  M S Jurgens; M Safy-Khan; M J H de Hair; J W J Bijlsma; P M J Welsing; J Tekstra; F P J G Lafeber; E H Sasso; J W G Jacobs
Journal:  Arthritis Res Ther       Date:  2020-09-09       Impact factor: 5.156

8.  Co-Design of a Disease Activity Based Self-Management Approach for Patients with Rheumatoid Arthritis.

Authors:  Marieke J Spijk-de Jonge; Sofie H M Manders; Anita M P Huis; Glyn Elwyn; Mart A F J van de Laar; Piet L C M van Riel; Marlies E J L Hulscher
Journal:  Mediterr J Rheumatol       Date:  2021-03-31

9.  Practice what you preach? An exploratory multilevel study on rheumatoid arthritis guideline adherence by rheumatologists.

Authors:  N Lesuis; A A den Broeder; M E J L Hulscher; R F van Vollenhoven
Journal:  RMD Open       Date:  2016-05-17

10.  Long-term disease and patient-reported outcomes of a continuous treat-to-target approach in patients with early rheumatoid arthritis in daily clinical practice.

Authors:  G A Versteeg; L M M Steunebrink; H E Vonkeman; P M Ten Klooster; A E van der Bijl; M A F J van de Laar
Journal:  Clin Rheumatol       Date:  2018-02-01       Impact factor: 2.980
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.